All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Renal involvement in Systemic Sclerosis

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023728%3A_____%2F19%3AN0000062" target="_blank" >RIV/00023728:_____/19:N0000062 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216208:11150/19:10406003 RIV/00179906:_____/19:10406003

  • Result on the web

    <a href="https://www.intechopen.com/books/new-insights-into-systemic-sclerosis/renal-involvement-in-systemic-sclerosis" target="_blank" >https://www.intechopen.com/books/new-insights-into-systemic-sclerosis/renal-involvement-in-systemic-sclerosis</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.5772/intechopen.87187" target="_blank" >10.5772/intechopen.87187</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Renal involvement in Systemic Sclerosis

  • Original language description

    Scleroderma renal crisis (SRC) is classical renal disease in systemic sclerosis (SSc). SRC is a relatively rare manifestation, approximately in 5% of patients. In terms of severity, manifestation in the form of SRC is the most common cause of acute organ failure. In SSc patients, SRC is defined as a new onset of accelerated arterial hypertension and rapidly progressive anuric or oliguric renal failure. SRC is primarily vascular injury with increased activity of the renin-angiotensin activity. These events lead to release or activation of cytokines and growth factors that result in the typical proliferative vascular lesions. Successful approach is routine use of angiotensin-converting enzyme inhibitors in the treatment of SRC (except prevention) and other advances in renal replacement therapy in SSc management. It is crucial to detect manifestations of SRC early and to manage appropriately in collaboration with intensive care medicine, cardiologists, and nephrologists. In contrast to SRC, clinical presentation of interstitial renal disease is poor, often without evidence of renal abnormality. Interestingly, other renal manifestations are glomerulonephritis and vasculitis. These manifestations are associated with overlapping mechanisms. The objective of this chapter is to focus on actual knowledge about the renal involvement in SSc and current treatment principles and possibilities.

  • Czech name

  • Czech description

Classification

  • Type

    C - Chapter in a specialist book

  • CEP classification

  • OECD FORD branch

    30226 - Rheumatology

Result continuities

  • Project

    <a href="/en/project/NV16-33542A" target="_blank" >NV16-33542A: The role of Hsp90 (Heat shock protein 90) in selected rheumatic diseases</a><br>

  • Continuities

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2019

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Book/collection name

    New Insight into Systemic Sclerosis

  • ISBN

    978-1-83962-204-5

  • Number of pages of the result

    22

  • Pages from-to

    41-62

  • Number of pages of the book

    148

  • Publisher name

    IntechOpen

  • Place of publication

    London

  • UT code for WoS chapter